Garrett Wright, MD
Anesthesiology · Oklahoma City, OKNPI 1306131982
Payments from drug & device makers
Across 755 payments — averaging $119.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$59K
- Medtronic$19K
- Boston Scientific$5K
- Abbott$2K
- Globus Medical$901
- Nalu Medical, Inc.$388
- plus $3K from 25 others
What the payments were for
- Consulting fees$10,01614%
- Speaking & faculty fees$39,12554%
- Travel & lodging$4,3536%
- Food & beverage$19,28226%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 366 | $58,950 |
| Medtronic(2 entities) | 63 | $18,816 |
| Boston Scientific | 28 | $5,435 |
| Abbott | 134 | $2,489 |
| Globus Medical | 16 | $901 |
| Nalu Medical, Inc. | 2 | $388 |
| Saluda Medical Americas, Inc. | 5 | $352 |
| AbbVie(2 entities) | 19 | $338 |
| Scilex Pharmaceuticals Inc. | 19 | $285 |
| Vertiflex, Inc. | 10 | $256 |
| Relievant Medsystems, Inc. | 2 | $242 |
| Amgen(2 entities) | 16 | $202 |
| Stryker | 1 | $153 |
| Si-bone, Inc. | 2 | $141 |
| Zyla Life Sciences, Inc. | 23 | $138 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $127 |
| IBSA Pharma Inc. | 7 | $111 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| GRT US Holding, Inc. | 5 | $71 |
| Kowa Pharmaceuticals America, Inc. | 3 | $70 |
| Vertos Medical, Inc. | 1 | $69 |
| Pacira Therapeutics, Inc. | 4 | $66 |
| SPR Therapeutics, Inc | 4 | $52 |
| Bioventus LLC | 3 | $49 |
| Pfizer | 4 | $47 |
| Foundation Fusion Solutions, LLC | 1 | $38 |
| Merck | 2 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Averitas Pharma Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$37,116
- Omnia$10,603
- SPECTRA WAVEWRITER$4,465
- Nevro$3,825
- Senza$877
- Intracept$758
- Proclaim Family of SCS IPGs$432
- Neuromodulation Dspsbls and Accs$412
- Nalu Neurostimulation System$374
- INTELLIS ADAPTIVESTIM$253
- Evoke$236
- SUPERION$235
- YUKON$153
- SlimTip lead DRG Lead$143
- Superion Indirect Decompression System$120
- Senza II$105
- GENERAL PAIN MANAGEMENT$101
How this compares
$89,982 in reported general payments places this provider in the 95th percentile of 476 anesthesiology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 185 | $45,456 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,408 | $37,739 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 835 | $27,973 |
| Gabapentin | 611 | $9,148 |
| BelbucaBuprenorphine Hcl | 16 | $8,336 |
| MovantikNaloxegol Oxalate | 18 | $7,296 |
| BelsomraSuvorexant | 17 | $7,181 |
| Tizanidine Hcl | 630 | $7,150 |
| Fentanyl | 48 | $5,089 |
| Pregabalin | 285 | $4,618 |
| Lidocaine | 43 | $3,692 |
| Cyclobenzaprine Hcl | 227 | $2,713 |
| Cephalexin | 152 | $2,620 |
| Methocarbamol | 189 | $2,584 |
| Amitriptyline Hcl | 315 | $2,315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $93 | $8,33616 claims |
| MerckBelsomra | $32 | $7,18117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 476 anesthesiology providers in Oklahoma.
Other anesthesiology in Oklahoma City
- Kenichi TanakaOklahoma City$2.1M
- Alberto de ArmendiOklahoma City$686K
- Kofi VandyckOklahoma City$92K
- Robert SchoapsOklahoma City$54K
- Ami AttaliOklahoma City$47K
- Aimee PakOklahoma City$33K
- Michael ElderOklahoma City$8K
- Brad StarkeyOklahoma City$8K
- George SmithOklahoma City$6K
- Chun KwanOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.